Karen Prange's Net Worth

$10.1 Million

Estimate Recalculated Jul 8, 2024 04:40PM EST

Who is Karen Prange?

Karen Prange has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include ViewRay, Inc., AtriCure, Inc., NEVRO CORP, Embecta Corp., CANTEL MEDICAL CORP, HENRY SCHEIN INC, and BOSTON SCIENTIFIC CORP.

SEC CIK

Karen Prange's CIK is 0001566083

Past Insider Trading and Trends

2016 was Karen Prange's most active year for acquiring shares with 9 total transactions. Karen Prange's most active month to acquire stocks was the month of January. 2016 was Karen Prange's most active year for disposing of shares, totalling 11 transactions. Karen Prange's most active month to dispose stocks was the month of January. 2022 saw Karen Prange paying a total of $100,001.50 for 105,854 shares, this is the most they've acquired in one year. In 2015 Karen Prange cashed out on 63,370 shares for a total of $553,785.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Embecta Corp. (EMBC) Snapshot price: $17.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+85.21%
11.46K
24.9K
Feb 7
Form 4
+114.60%
6.98K
13.07K
Feb 9
Form 4
6.02K
6.02K
Apr 1
Form 3
0
0
No matching records found

BOSTON SCIENTIFIC CORP (BSX) Snapshot price: $64.9

SVP&Pres, Uro & Pelvic Health

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-27.75%
-14.75K
$17.27
-$254,748.53
38.4K
Scheduled
Mar 8
Form 4
+3.85%
1.97K
$17.21
-$30,169.13
53.14K
Feb 28
Form 4
+2.22%
1.11K
$17.33
-$17,174.03
51.17K
Feb 24
Form 4
+2.66%
1.3K
$17.24
-$17,257.24
50.06K
Feb 23
Form 4
+106.22%
25.12K
$17.26
-$208,742.44
48.77K
Feb 22
Form 4
-20.82%
-6.22K
$16.05
-$99,785.45
23.65K
Feb 8
Form 4
+71.33%
12.43K
$18.44
-$118,624.52
29.86K
Jan 1
Form 4
-50.04%
-17.46K
$17.66
-$308,307.87
17.43K
Scheduled
Jul 7
Form 4
+100.15%
17.46K
$17.57
-$147,693.42
34.89K
Jul 2
Form 4
-12.51%
-2.49K
$16.79
-$41,837.69
17.43K
Scheduled
Mar 3
Form 4
+14.30%
2.49K
$16.90
-$20,770.10
19.92K
Feb 28
Form 4
-6.98%
-1.31K
$16.80
-$21,963.22
17.43K
Scheduled
Feb 27
Form 4
+7.50%
1.31K
$16.62
-$13,212.90
18.74K
Feb 24
Form 4
0
0
Feb 23
Form 4
-53.12%
-19.75K
$12.64
-$249,606.81
17.43K
Scheduled
Dec 10
Form 4
+88.36%
17.44K
$13.13
-$110,541.47
37.18K
Jul 2
Form 4
+13.25%
2.31K
$13.10
-$18,484.10
19.74K
Feb 28
Form 4
0
0
Feb 24
Form 4
17.43K
$9.17
-$77,321.44
17.43K
Jul 2
Form 4
0
0
Feb 28
Form 3
0
0
No matching records found

HENRY SCHEIN INC (HSIC) Snapshot price: $75.73

EVP&CEO Gl.AH.Med.Den.Sur.Grp

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+45.12%
19.56K
62.9K
Mar 2
Form 4
+68.07%
8.78K
21.67K
Mar 6
Form 4
12.89K
12.89K
Jun 10
Form 3
0
0
No matching records found

ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-93.64%
-129.47K
$0.07
-$8,807.55
8.8K
Jul 19 - Jul 21
Form 4
+65.08%
54.51K
138.26K
Jun 13
Form 4
+81.47%
37.6K
$2.66
$100,001.50
83.75K
May 10
Form 4
+133.58%
26.39K
46.15K
Jul 1
Form 4
19.76K
19.76K
Jun 14
Form 3
0
0
No matching records found

AtriCure, Inc. (ATRC) Snapshot price: $33.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+48.25%
7.79K
23.93K
May 13
Form 4
-4.23%
-713.00
$47.89
-$34,145.57
16.14K
Jun 8
Form 4
+23.31%
3.19K
16.85K
May 25
Form 4
+35.28%
3.56K
13.67K
May 25
Form 4
+20.94%
1.75K
10.1K
May 20
Form 4
+41.55%
2.45K
8.35K
May 20
Form 4
5.9K
5.9K
Dec 4
Form 3
0
0
No matching records found